The FDA has approved Biogen’s Alzheimer’s drug Leqembi for injection to treat individuals with mild cognitive impairment or mild dementia. The drug can now be administered as a once-weekly injection using an autoinjector device, compared to the previous method of IV infusions every two weeks, according to an Aug. 29 news release from the drugmaker. […] The post FDA approves weekly Alzheimer’s drug appeared first on Becker's Hospital Review | Healthcare News & Analysis.
